Indalo Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Indalo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis (NCT03949530) | Indalo Therapeutics, Inc. | 2019-04-16 |
Track Indalo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.